Pulse Biosciences Inc (PLSE) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Pulse Biosciences Inc   (NASDAQ: PLSE)


Pulse Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pulse Biosciences Inc's ROI in the second quarter of 2026?
Pulse Biosciences Inc recorded a cumulative net loss of $-80 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -88.44%.

Within the Healthcare sector 567 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3856 to 3938.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -18.74 % -0.01 % 47.11 % 110.94 % 132.68 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 105 72 87 99 111
Return On Investment (TTM) -88.44 % -80.88 % -68.89 % -65.22 % -61.07 %
PLSE's Overall Ranking # 3938 # 3856 # 2827 # 3383 # 3130
Seq. Investment Change TTM -1.81 % -12.73 % -7.81 % 2.86 % 20.83 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -80 -75 -73 -75 -68




Return On Investment PLSE's Ranking
Within: No.
Industry # 134
Sector # 568
Overall # 3938

Return On Investment Statistics
High Average Low
-39.74 %
-86.82 %
-146.01 %
(Dec 31 2016)   (Jun 30 2022)







Financial Statements
Pulse Biosciences Inc's II. Quarter Investments $ 105 Millions PLSE's Balance sheet
Pulse Biosciences Inc's II. Quarter Income $ -25 Millions Quarterly PLSE's Income Statement
PLSE's Income by Division See PLSE's Income by Division


PLSE Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 87 122 52 72 46
Y / Y Investment Growth -29.24 % 133.39 % -27.05 % 57.22 % 35.67 %
Net Income in Millions -73 -54 -42 -59 -64
Y / Y Net Income Growth - - - - -
Annual Return On Investment -84.03 % -43.78 % -80.48 % -81.37 % -139.21 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PLSE's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PLSE's Competitors
Subscribers only: Roi for Pulse Biosciences Inc's Suppliers
Subscribers only: Return On Investment for PLSE's Customers

Other Ratios
PLSE's Roa PLSE's Inventory Turnover Ratio PLSE's Growth Rates PLSE's Dividend Statistics
PLSE's Profitability Ratios PLSE's Asset Turnover Ratio PLSE's Dividend Growth
PLSE's Roe PLSE's Valuation Ratios PLSE's Financial Strength Ratios PLSE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-08T21:36:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.